IL33 and glioma: Our previous results suggest that IL-33 promotes tumour progression via upregulation of the expression of matrix metalloproteinase (MMP)-2 and MMP-9 in glioma cells25, while TNC has been suggested to upregulate MMP-2 and MMP-9 expression in numerous cell types49,50.